J. Garweg, E. Baglivo, F. Freiberg, M. Pfau, I. Pfister, S. Michels, S. Zandi
Response of Postoperative and Chronic Uveitic Cystoid Macular Edema to a Dexamethasone-Based Intravitreal Implant (Ozurdex)
1.9.2016, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 32(7):442-50
J. Garweg, S. Zandi
Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
1.7.2016, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 1256-65
J. Garweg
Diabetische Retinopathie und Makulopathie nehmen zu
24.3.2016, Ars Medici (Schweizer Zeitschrift für Hausarztmedizin), 106:268-271
J. Garweg
Alterbedingte Makuladegeneration – Ursachen und Therapie
1.3.2015, Dialog, Dialog38 4-7
S. Wenger, C. Luvet, J. Garweg
Regionalanästhesie bei intraokularen Eingriffen
2015, Klinische Monatsblätter für Augenheilkunde, 232: 367-371
M. Wallon, J. Garweg, M. Abrahamowicz, C. Cornu, S. Vinault, C. Quantin, C. Bonithon-Kopp, S. Picot, F. Peyron, C. Binquet
Ophthalmic Outcomes of Congenital Toxoplasmosis
17.2.2014, Pediatrics, 2014 133(3):e601-8
F. Körner, U. Körner-Stiefbold, J. Garweg
Systemic corticosteroids reduce the risk of cellophane membranes after retinal detachment surgery: a prospective randomized placebo-controlled double-blind clinical trial
21.1.2012, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, Volume 250, Number 7 (2012), 981-987, DOI: 10.1007/s00417-011-1919-y
C. Tappeiner, F. Flückiger, M. Böhnke, D. Goldblum, J. Garweg
Effect of topical anesthetic agents and ethanol on corneoepithelial wound healing in an ex vivo whole-globe porcine model
2012, Journal of cataract and refractive surgery, 0886-3350, doi:10.1016/j.jcrs.2011.09.043
C. Tappeiner, J. Garweg
Retinal vascular occlusion after vitrectomy with retrobulbar anesthesia-observational case series and survey of literature
1.12.2011, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 249(12):1831-5
F. Peyron, J. Garweg, M. Wallon, E. Descolux, M. Rolland, J. Barth
Long-term Impact of Treated Congenital Toxoplasmosis on Quality of Life and Visual Performance
1.7.2011, The Pediatric Infectious Disease Journal, Volume 30, Number 7, July 2011
J. Garweg, C. Tappeiner
Differenzialdiagnose der infektiösen posterioren Uveitis
2011, Klinische Monatsblätter für Augenheilkunde, 2011 228: 268-272
J. Garweg, Y. de Kozak, B. Goldenberg, M. Böhnke
Anti-retinal autoantibodies in experimental ocular and systemic toxoplasmosis
3.12.2009, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 248: 573-584
I. Lahmar, A. Abou-Bacar, T. Abdelrahman, M. Guinard, H. Babba, S. Benyahia, M. Kairallah, C. Speeg-Schatz, T. Bourcier, A. Sauer, M. Mousli, J. Garweg, E. Candolfi
Cytokine Profiles in Toxoplasmic and Viral Uveitis
1.4.2009, The Journal of Infectious Diseases, Volume 199, Issue 8, Page 1239-1249
J. Garweg, F. Körner
Outcome indicators for vitrectomy in Terson syndrome
1.3.2009, Acta ophthalmologica Scandinavica, Volume 87, Issue 2, Pages: 222-226
N. Torun, Z. Sherif, J. Garweg, U. Pleyer
Diagnostik und Behandlung der okulären Toxoplasmose
Eine Bestandsaufnahme unter deutschsprachigen Ophthalmologen
28.3.2008, Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 105(11):1023-1028. DOI:10.1007/s00347-008-1694-2
D. Goldblum, C. Bachmann, C. Tappeiner, J. Garweg, B. Früh
Comparison of oral antiviral therapy with valacyclovir or acyclovir after penetrating keratoplasty for herpetic keratitis
2008, The British journal of ophthalmology, 92: 1201 - 5
E. Gollub, V. Leroy, R. Gilbert, G. Chêne, M. Wallon
Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancy
European Toxoprevention Study Group (EUROTOXO)
2008, European journal of obstetrics, gynecology, and reproductive biology., 136: 137 - 45
S. Morisset, F. Peyron, J. Lobry, J. Garweg, J. Ferrandiz, K. Musset, J. Gomez-Marin, A. de la Torre, M. Demar, B. Carme, C. Mercier, J. Garin, M. Cesbron-Delauw
Serotyping of Toxoplasma gondii: striking homogeneous pattern between symptomatic and asymptomatic infections within Europe and South America
2008, Microbes and infection / Institut Pasteur, 10: 742 - 7
J. Garweg, D. Bergstein, B. Windisch, F. Körner, M. Halberstadt
Recovery of visual field and acuity after removal of epiretinal and inner limiting membranes
2008, The British journal of ophthalmology, Feb 92(2): 220 - 4
J. Garweg, J. Scherrer, M. Halberstadt
Recurrence Characteristics in European Patients with Ocular Toxoplasmosis
2008, The British journal of ophthalmology, 92: 1253 - 6